Synthesis and Biological Evaluation of Bupropion Analogues as Potential Pharmacotherapies for Cocaine Addiction

A series of bupropion (1a) analogues (1b−1ff) were synthesized, and their in vitro and in vivo pharmacological properties evaluated with the goal of developing a 1a analogue that had better properties for treating addictions. Their in vitro pharmacological properties were examined by [3H]dopamine ([...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of medicinal chemistry 2009-11, Vol.52 (21), p.6768-6781
Hauptverfasser: Carroll, F. Ivy, Blough, Bruce E, Abraham, Philip, Mills, Andrew C, Holleman, J. Ashley, Wolckenhauer, Scott A, Decker, Ann M, Landavazo, Antonio, McElroy, K. Timothy, Navarro, Hernán A, Gatch, Michael B, Forster, Michael J
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 6781
container_issue 21
container_start_page 6768
container_title Journal of medicinal chemistry
container_volume 52
creator Carroll, F. Ivy
Blough, Bruce E
Abraham, Philip
Mills, Andrew C
Holleman, J. Ashley
Wolckenhauer, Scott A
Decker, Ann M
Landavazo, Antonio
McElroy, K. Timothy
Navarro, Hernán A
Gatch, Michael B
Forster, Michael J
description A series of bupropion (1a) analogues (1b−1ff) were synthesized, and their in vitro and in vivo pharmacological properties evaluated with the goal of developing a 1a analogue that had better properties for treating addictions. Their in vitro pharmacological properties were examined by [3H]dopamine ([3H]DA), [3H]serotonin ([3H]5HT), and [3H]norepinephrine ([3H]NE) uptake inhibition studies, and by binding studies at the dopamine, serotonin, and norepinephrine transporters using [125I]RTI-55 in cloned transporters. Several analogues showed increased [3H]DA uptake inhibition with reduced or little change in [3H]5HT and [3H]NE uptake inhibition relative to bupropion. Thirty-five analogues were evaluated in a 1 h locomotor activity observation test and 32 in an 8 h locomotor activity observation test and compared to the locomotor activity of cocaine. Twenty-four analogues were evaluated for generalization to cocaine drug discrimination after i.p. administration, and twelve analogues were tested in a time course cocaine discrimination study using oral administration. 2-(N-Cyclopropylamino)-3-chloropropiophenone (1x) had the most favorable in vitro efficacy and in vivo pharmacological profile for an indirect dopamine agonist pharmacotherapy for treating cocaine, methamphetamine, nicotine, and other drugs of abuse addiction.
doi_str_mv 10.1021/jm901189z
format Article
fullrecord <record><control><sourceid>acs_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1021_jm901189z</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>b253272622</sourcerecordid><originalsourceid>FETCH-LOGICAL-a384t-d0f0b85572c1cf445141e101df5732fd233e754d1b1adbf49723f897367999e33</originalsourceid><addsrcrecordid>eNpt0E1LwzAYB_AgipvTg19AcvHgoZonSdf2uI35AgMH6rmkeXEZXVOSVpif3oyN7eIpPOT3_B_4I3QL5BEIhaf1piAAefF7hoaQUpLwnPBzNCSE0oSOKRugqxDWhBAGlF2iARQ5hTTLhsh9bJtupYMNWDQKT62r3beVosbzH1H3orOuwc7gad961-6GSSMi6XVcCHjpOt10NvLlSviNkC6GedHa-G2cxzMnhW00nihl5S7rGl0YUQd9c3hH6Ot5_jl7TRbvL2-zySIRLOddooghVZ6mGZUgDecpcNBAQJk0Y9QoypjOUq6gAqEqw4uMMpMXGRtnRVFoxkboYZ8rvQvBa1O23m6E35ZAyl1p5bG0aO_2tu2rjVYneWgpgvsDECFWY7xopA1HRymQnHJ2ckKGcu16H6sK_xz8A7nRgUM</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Synthesis and Biological Evaluation of Bupropion Analogues as Potential Pharmacotherapies for Cocaine Addiction</title><source>ACS Publications</source><source>MEDLINE</source><creator>Carroll, F. Ivy ; Blough, Bruce E ; Abraham, Philip ; Mills, Andrew C ; Holleman, J. Ashley ; Wolckenhauer, Scott A ; Decker, Ann M ; Landavazo, Antonio ; McElroy, K. Timothy ; Navarro, Hernán A ; Gatch, Michael B ; Forster, Michael J</creator><creatorcontrib>Carroll, F. Ivy ; Blough, Bruce E ; Abraham, Philip ; Mills, Andrew C ; Holleman, J. Ashley ; Wolckenhauer, Scott A ; Decker, Ann M ; Landavazo, Antonio ; McElroy, K. Timothy ; Navarro, Hernán A ; Gatch, Michael B ; Forster, Michael J</creatorcontrib><description>A series of bupropion (1a) analogues (1b−1ff) were synthesized, and their in vitro and in vivo pharmacological properties evaluated with the goal of developing a 1a analogue that had better properties for treating addictions. Their in vitro pharmacological properties were examined by [3H]dopamine ([3H]DA), [3H]serotonin ([3H]5HT), and [3H]norepinephrine ([3H]NE) uptake inhibition studies, and by binding studies at the dopamine, serotonin, and norepinephrine transporters using [125I]RTI-55 in cloned transporters. Several analogues showed increased [3H]DA uptake inhibition with reduced or little change in [3H]5HT and [3H]NE uptake inhibition relative to bupropion. Thirty-five analogues were evaluated in a 1 h locomotor activity observation test and 32 in an 8 h locomotor activity observation test and compared to the locomotor activity of cocaine. Twenty-four analogues were evaluated for generalization to cocaine drug discrimination after i.p. administration, and twelve analogues were tested in a time course cocaine discrimination study using oral administration. 2-(N-Cyclopropylamino)-3-chloropropiophenone (1x) had the most favorable in vitro efficacy and in vivo pharmacological profile for an indirect dopamine agonist pharmacotherapy for treating cocaine, methamphetamine, nicotine, and other drugs of abuse addiction.</description><identifier>ISSN: 0022-2623</identifier><identifier>EISSN: 1520-4804</identifier><identifier>DOI: 10.1021/jm901189z</identifier><identifier>PMID: 19821577</identifier><identifier>CODEN: JMCMAR</identifier><language>eng</language><publisher>Columbus, OH: American Chemical Society</publisher><subject>Adrenergic Uptake Inhibitors - chemical synthesis ; Adrenergic Uptake Inhibitors - chemistry ; Adrenergic Uptake Inhibitors - pharmacology ; Animals ; Biological and medical sciences ; Bupropion - analogs &amp; derivatives ; Bupropion - chemical synthesis ; Bupropion - pharmacology ; Cell Line ; Cocaine - pharmacology ; Cocaine-Related Disorders - drug therapy ; Discrimination Learning - drug effects ; Dopamine Plasma Membrane Transport Proteins - metabolism ; Dopamine Uptake Inhibitors - chemical synthesis ; Dopamine Uptake Inhibitors - chemistry ; Dopamine Uptake Inhibitors - pharmacology ; Drug addictions ; Humans ; Medical sciences ; Mice ; Motor Activity - drug effects ; Neuropharmacology ; Norepinephrine Plasma Membrane Transport Proteins - metabolism ; Pharmacology. Drug treatments ; Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer ; Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer..., (alzheimer disease) ; Psychology. Psychoanalysis. Psychiatry ; Psychopharmacology ; Radioligand Assay ; Rats ; Serotonin Plasma Membrane Transport Proteins - metabolism ; Serotonin Uptake Inhibitors - chemical synthesis ; Serotonin Uptake Inhibitors - chemistry ; Serotonin Uptake Inhibitors - pharmacology ; Structure-Activity Relationship ; Toxicology</subject><ispartof>Journal of medicinal chemistry, 2009-11, Vol.52 (21), p.6768-6781</ispartof><rights>Copyright © 2009 American Chemical Society</rights><rights>2015 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-a384t-d0f0b85572c1cf445141e101df5732fd233e754d1b1adbf49723f897367999e33</citedby><cites>FETCH-LOGICAL-a384t-d0f0b85572c1cf445141e101df5732fd233e754d1b1adbf49723f897367999e33</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://pubs.acs.org/doi/pdf/10.1021/jm901189z$$EPDF$$P50$$Gacs$$H</linktopdf><linktohtml>$$Uhttps://pubs.acs.org/doi/10.1021/jm901189z$$EHTML$$P50$$Gacs$$H</linktohtml><link.rule.ids>314,776,780,2752,27053,27901,27902,56713,56763</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=22108243$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/19821577$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Carroll, F. Ivy</creatorcontrib><creatorcontrib>Blough, Bruce E</creatorcontrib><creatorcontrib>Abraham, Philip</creatorcontrib><creatorcontrib>Mills, Andrew C</creatorcontrib><creatorcontrib>Holleman, J. Ashley</creatorcontrib><creatorcontrib>Wolckenhauer, Scott A</creatorcontrib><creatorcontrib>Decker, Ann M</creatorcontrib><creatorcontrib>Landavazo, Antonio</creatorcontrib><creatorcontrib>McElroy, K. Timothy</creatorcontrib><creatorcontrib>Navarro, Hernán A</creatorcontrib><creatorcontrib>Gatch, Michael B</creatorcontrib><creatorcontrib>Forster, Michael J</creatorcontrib><title>Synthesis and Biological Evaluation of Bupropion Analogues as Potential Pharmacotherapies for Cocaine Addiction</title><title>Journal of medicinal chemistry</title><addtitle>J. Med. Chem</addtitle><description>A series of bupropion (1a) analogues (1b−1ff) were synthesized, and their in vitro and in vivo pharmacological properties evaluated with the goal of developing a 1a analogue that had better properties for treating addictions. Their in vitro pharmacological properties were examined by [3H]dopamine ([3H]DA), [3H]serotonin ([3H]5HT), and [3H]norepinephrine ([3H]NE) uptake inhibition studies, and by binding studies at the dopamine, serotonin, and norepinephrine transporters using [125I]RTI-55 in cloned transporters. Several analogues showed increased [3H]DA uptake inhibition with reduced or little change in [3H]5HT and [3H]NE uptake inhibition relative to bupropion. Thirty-five analogues were evaluated in a 1 h locomotor activity observation test and 32 in an 8 h locomotor activity observation test and compared to the locomotor activity of cocaine. Twenty-four analogues were evaluated for generalization to cocaine drug discrimination after i.p. administration, and twelve analogues were tested in a time course cocaine discrimination study using oral administration. 2-(N-Cyclopropylamino)-3-chloropropiophenone (1x) had the most favorable in vitro efficacy and in vivo pharmacological profile for an indirect dopamine agonist pharmacotherapy for treating cocaine, methamphetamine, nicotine, and other drugs of abuse addiction.</description><subject>Adrenergic Uptake Inhibitors - chemical synthesis</subject><subject>Adrenergic Uptake Inhibitors - chemistry</subject><subject>Adrenergic Uptake Inhibitors - pharmacology</subject><subject>Animals</subject><subject>Biological and medical sciences</subject><subject>Bupropion - analogs &amp; derivatives</subject><subject>Bupropion - chemical synthesis</subject><subject>Bupropion - pharmacology</subject><subject>Cell Line</subject><subject>Cocaine - pharmacology</subject><subject>Cocaine-Related Disorders - drug therapy</subject><subject>Discrimination Learning - drug effects</subject><subject>Dopamine Plasma Membrane Transport Proteins - metabolism</subject><subject>Dopamine Uptake Inhibitors - chemical synthesis</subject><subject>Dopamine Uptake Inhibitors - chemistry</subject><subject>Dopamine Uptake Inhibitors - pharmacology</subject><subject>Drug addictions</subject><subject>Humans</subject><subject>Medical sciences</subject><subject>Mice</subject><subject>Motor Activity - drug effects</subject><subject>Neuropharmacology</subject><subject>Norepinephrine Plasma Membrane Transport Proteins - metabolism</subject><subject>Pharmacology. Drug treatments</subject><subject>Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer</subject><subject>Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer..., (alzheimer disease)</subject><subject>Psychology. Psychoanalysis. Psychiatry</subject><subject>Psychopharmacology</subject><subject>Radioligand Assay</subject><subject>Rats</subject><subject>Serotonin Plasma Membrane Transport Proteins - metabolism</subject><subject>Serotonin Uptake Inhibitors - chemical synthesis</subject><subject>Serotonin Uptake Inhibitors - chemistry</subject><subject>Serotonin Uptake Inhibitors - pharmacology</subject><subject>Structure-Activity Relationship</subject><subject>Toxicology</subject><issn>0022-2623</issn><issn>1520-4804</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2009</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpt0E1LwzAYB_AgipvTg19AcvHgoZonSdf2uI35AgMH6rmkeXEZXVOSVpif3oyN7eIpPOT3_B_4I3QL5BEIhaf1piAAefF7hoaQUpLwnPBzNCSE0oSOKRugqxDWhBAGlF2iARQ5hTTLhsh9bJtupYMNWDQKT62r3beVosbzH1H3orOuwc7gad961-6GSSMi6XVcCHjpOt10NvLlSviNkC6GedHa-G2cxzMnhW00nihl5S7rGl0YUQd9c3hH6Ot5_jl7TRbvL2-zySIRLOddooghVZ6mGZUgDecpcNBAQJk0Y9QoypjOUq6gAqEqw4uMMpMXGRtnRVFoxkboYZ8rvQvBa1O23m6E35ZAyl1p5bG0aO_2tu2rjVYneWgpgvsDECFWY7xopA1HRymQnHJ2ckKGcu16H6sK_xz8A7nRgUM</recordid><startdate>20091112</startdate><enddate>20091112</enddate><creator>Carroll, F. Ivy</creator><creator>Blough, Bruce E</creator><creator>Abraham, Philip</creator><creator>Mills, Andrew C</creator><creator>Holleman, J. Ashley</creator><creator>Wolckenhauer, Scott A</creator><creator>Decker, Ann M</creator><creator>Landavazo, Antonio</creator><creator>McElroy, K. Timothy</creator><creator>Navarro, Hernán A</creator><creator>Gatch, Michael B</creator><creator>Forster, Michael J</creator><general>American Chemical Society</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>20091112</creationdate><title>Synthesis and Biological Evaluation of Bupropion Analogues as Potential Pharmacotherapies for Cocaine Addiction</title><author>Carroll, F. Ivy ; Blough, Bruce E ; Abraham, Philip ; Mills, Andrew C ; Holleman, J. Ashley ; Wolckenhauer, Scott A ; Decker, Ann M ; Landavazo, Antonio ; McElroy, K. Timothy ; Navarro, Hernán A ; Gatch, Michael B ; Forster, Michael J</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-a384t-d0f0b85572c1cf445141e101df5732fd233e754d1b1adbf49723f897367999e33</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2009</creationdate><topic>Adrenergic Uptake Inhibitors - chemical synthesis</topic><topic>Adrenergic Uptake Inhibitors - chemistry</topic><topic>Adrenergic Uptake Inhibitors - pharmacology</topic><topic>Animals</topic><topic>Biological and medical sciences</topic><topic>Bupropion - analogs &amp; derivatives</topic><topic>Bupropion - chemical synthesis</topic><topic>Bupropion - pharmacology</topic><topic>Cell Line</topic><topic>Cocaine - pharmacology</topic><topic>Cocaine-Related Disorders - drug therapy</topic><topic>Discrimination Learning - drug effects</topic><topic>Dopamine Plasma Membrane Transport Proteins - metabolism</topic><topic>Dopamine Uptake Inhibitors - chemical synthesis</topic><topic>Dopamine Uptake Inhibitors - chemistry</topic><topic>Dopamine Uptake Inhibitors - pharmacology</topic><topic>Drug addictions</topic><topic>Humans</topic><topic>Medical sciences</topic><topic>Mice</topic><topic>Motor Activity - drug effects</topic><topic>Neuropharmacology</topic><topic>Norepinephrine Plasma Membrane Transport Proteins - metabolism</topic><topic>Pharmacology. Drug treatments</topic><topic>Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer</topic><topic>Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer..., (alzheimer disease)</topic><topic>Psychology. Psychoanalysis. Psychiatry</topic><topic>Psychopharmacology</topic><topic>Radioligand Assay</topic><topic>Rats</topic><topic>Serotonin Plasma Membrane Transport Proteins - metabolism</topic><topic>Serotonin Uptake Inhibitors - chemical synthesis</topic><topic>Serotonin Uptake Inhibitors - chemistry</topic><topic>Serotonin Uptake Inhibitors - pharmacology</topic><topic>Structure-Activity Relationship</topic><topic>Toxicology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Carroll, F. Ivy</creatorcontrib><creatorcontrib>Blough, Bruce E</creatorcontrib><creatorcontrib>Abraham, Philip</creatorcontrib><creatorcontrib>Mills, Andrew C</creatorcontrib><creatorcontrib>Holleman, J. Ashley</creatorcontrib><creatorcontrib>Wolckenhauer, Scott A</creatorcontrib><creatorcontrib>Decker, Ann M</creatorcontrib><creatorcontrib>Landavazo, Antonio</creatorcontrib><creatorcontrib>McElroy, K. Timothy</creatorcontrib><creatorcontrib>Navarro, Hernán A</creatorcontrib><creatorcontrib>Gatch, Michael B</creatorcontrib><creatorcontrib>Forster, Michael J</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><jtitle>Journal of medicinal chemistry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Carroll, F. Ivy</au><au>Blough, Bruce E</au><au>Abraham, Philip</au><au>Mills, Andrew C</au><au>Holleman, J. Ashley</au><au>Wolckenhauer, Scott A</au><au>Decker, Ann M</au><au>Landavazo, Antonio</au><au>McElroy, K. Timothy</au><au>Navarro, Hernán A</au><au>Gatch, Michael B</au><au>Forster, Michael J</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Synthesis and Biological Evaluation of Bupropion Analogues as Potential Pharmacotherapies for Cocaine Addiction</atitle><jtitle>Journal of medicinal chemistry</jtitle><addtitle>J. Med. Chem</addtitle><date>2009-11-12</date><risdate>2009</risdate><volume>52</volume><issue>21</issue><spage>6768</spage><epage>6781</epage><pages>6768-6781</pages><issn>0022-2623</issn><eissn>1520-4804</eissn><coden>JMCMAR</coden><abstract>A series of bupropion (1a) analogues (1b−1ff) were synthesized, and their in vitro and in vivo pharmacological properties evaluated with the goal of developing a 1a analogue that had better properties for treating addictions. Their in vitro pharmacological properties were examined by [3H]dopamine ([3H]DA), [3H]serotonin ([3H]5HT), and [3H]norepinephrine ([3H]NE) uptake inhibition studies, and by binding studies at the dopamine, serotonin, and norepinephrine transporters using [125I]RTI-55 in cloned transporters. Several analogues showed increased [3H]DA uptake inhibition with reduced or little change in [3H]5HT and [3H]NE uptake inhibition relative to bupropion. Thirty-five analogues were evaluated in a 1 h locomotor activity observation test and 32 in an 8 h locomotor activity observation test and compared to the locomotor activity of cocaine. Twenty-four analogues were evaluated for generalization to cocaine drug discrimination after i.p. administration, and twelve analogues were tested in a time course cocaine discrimination study using oral administration. 2-(N-Cyclopropylamino)-3-chloropropiophenone (1x) had the most favorable in vitro efficacy and in vivo pharmacological profile for an indirect dopamine agonist pharmacotherapy for treating cocaine, methamphetamine, nicotine, and other drugs of abuse addiction.</abstract><cop>Columbus, OH</cop><pub>American Chemical Society</pub><pmid>19821577</pmid><doi>10.1021/jm901189z</doi><tpages>14</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0022-2623
ispartof Journal of medicinal chemistry, 2009-11, Vol.52 (21), p.6768-6781
issn 0022-2623
1520-4804
language eng
recordid cdi_crossref_primary_10_1021_jm901189z
source ACS Publications; MEDLINE
subjects Adrenergic Uptake Inhibitors - chemical synthesis
Adrenergic Uptake Inhibitors - chemistry
Adrenergic Uptake Inhibitors - pharmacology
Animals
Biological and medical sciences
Bupropion - analogs & derivatives
Bupropion - chemical synthesis
Bupropion - pharmacology
Cell Line
Cocaine - pharmacology
Cocaine-Related Disorders - drug therapy
Discrimination Learning - drug effects
Dopamine Plasma Membrane Transport Proteins - metabolism
Dopamine Uptake Inhibitors - chemical synthesis
Dopamine Uptake Inhibitors - chemistry
Dopamine Uptake Inhibitors - pharmacology
Drug addictions
Humans
Medical sciences
Mice
Motor Activity - drug effects
Neuropharmacology
Norepinephrine Plasma Membrane Transport Proteins - metabolism
Pharmacology. Drug treatments
Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer
Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer..., (alzheimer disease)
Psychology. Psychoanalysis. Psychiatry
Psychopharmacology
Radioligand Assay
Rats
Serotonin Plasma Membrane Transport Proteins - metabolism
Serotonin Uptake Inhibitors - chemical synthesis
Serotonin Uptake Inhibitors - chemistry
Serotonin Uptake Inhibitors - pharmacology
Structure-Activity Relationship
Toxicology
title Synthesis and Biological Evaluation of Bupropion Analogues as Potential Pharmacotherapies for Cocaine Addiction
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-09T10%3A10%3A52IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-acs_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Synthesis%20and%20Biological%20Evaluation%20of%20Bupropion%20Analogues%20as%20Potential%20Pharmacotherapies%20for%20Cocaine%20Addiction&rft.jtitle=Journal%20of%20medicinal%20chemistry&rft.au=Carroll,%20F.%20Ivy&rft.date=2009-11-12&rft.volume=52&rft.issue=21&rft.spage=6768&rft.epage=6781&rft.pages=6768-6781&rft.issn=0022-2623&rft.eissn=1520-4804&rft.coden=JMCMAR&rft_id=info:doi/10.1021/jm901189z&rft_dat=%3Cacs_cross%3Eb253272622%3C/acs_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/19821577&rfr_iscdi=true